Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...

New obesity criteria that add waist and body fat measures to BMI could classify nearly 70% of U.S. adults as obese, according ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

A new definition of obesity could nearly double the prevalence of U.S. adults with the condition, a new study published ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.

Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting ...

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

Addressing Louisiana's obesity epidemic." This series will shine a spotlight on one of Louisiana’s biggest wellness issues ...

Pfizer Inc. (NYSE: PFE) is included among the 13 Best Dividend Stocks Paying Over 6%.